Compare Medpace Holdings Inc (MEDP) vs Roundhill Russell 2000 0DTE Covered Call Strat ETF (RDTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Roundhill Russell 2000 0DTE Covered Call Strat ETF — how do they compare? Medpace Holdings Inc trades at $612.05 (market cap $16.82B), while Roundhill Russell 2000 0DTE Covered Call Strat ETF trades at $26.12 (market cap $159.33M). The key difference: Medpace Holdings Inc is far larger — about 105.6× Roundhill Russell 2000 0DTE Covered Call Strat ETF's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Roundhill Russell 2000 0DTE Covered Call Strat ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Roundhill Russell 2000 0DTE Covered Call Strat ETF for 54 Days on average.
| MEDP | RDTE | |
|---|---|---|
Market Cap | $16.82B | $159.33M |
Volume | 223,093 | 248,058 |
Sector | Health | Income / Options Overlay |
52-Week High | $630.19 | $33.66 |
52-Week Low | $393.42 | $25.96 |
Typical Hold Time | 14 Days | 54 Days |
Enterprise Value | $16.44B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $612.05, up 1.29% today, near its consensus price target of $620.44. The stock shows strong profitability with a 17.67% net margin and has beaten earnings estimates for the last three quarters. Technical indicators are neutral overall, with support at $595 and resistance at $612. Recent news highlights CEO stock sales and institutional position changes, while the company prepares to report Q3 2026 results on October 21.
Outlook remains positive given consistent earnings beats and projected revenue growth to $2.8B in 2026. Risks include high valuation multiples (P/E 35.41) and insider selling. Analyst consensus is cautious with 79% hold ratings, suggesting limited near-term upside but solid fundamental support for long-term holders.
RDTE trades at $26.12, showing minimal daily movement with a slight decline of 0.08%. The technical outlook is bearish, driven by negative moving average signals, while oscillators are neutral. The ETF has a history of frequent, small dividend payments, but key valuation and profitability ratios are unavailable. Recent news highlights concerns about capital erosion risk in covered-call strategies compared to peers.
The outlook for RDTE is cautious due to bearish technicals and media skepticism about its income strategy's sustainability. Investment appeal hinges on high yield, but risks include capital depreciation and underperformance versus benchmarks. Investors should weigh income generation against potential long-term value erosion in a competitive ETF landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Roundhill Russell 2000 0DTE Covered Call Strat ETF
RDTE is an actively managed ETF that seeks to generate income through a covered call strategy on the Russell 2000 Index. The fund primarily holds a portfolio of short-term U.S. government securities and sells 0-DTE (zero days to expiration) index call options on the Russell 2000. This highly tactical strategy aims to maximize premium capture by exploiting the high time decay of options that are expiring on the same day, which provides enhanced income but also exposes the fund to significant volatility and risks associated with daily options settlement.
Read more on RDTE →
